Is SGLT2 Inhibitor-Associated Ketoacidosis Treated With Enough Insulin?
(MedPage Today) -- Patients with SGLT2 inhibitor-associated diabetic ketoacidosis (DKA) received significantly lower doses of insulin in the first 24 hours of treatment compared with patients with type 1 diabetes DKA, according to a retrospective...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 1 | Endocrinology | Heart | Insulin | SGLT2 Inhibitors